Cargando…

Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice

The recent emergence of a causal link between Epstein-Barr virus (EBV) and multiple sclerosis has generated considerable interest in the development of an effective vaccine against EBV. Here we describe a vaccine formulation based on a lymph node targeting Amphiphile vaccine adjuvant, Amphiphile-CpG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasari, Vijayendra, McNeil, Lisa K., Beckett, Kirrilee, Solomon, Matthew, Ambalathingal, George, Thuy, T. Le, Panikkar, Archana, Smith, Caitlyn, Steinbuck, Martin P., Jakubowski, Aniela, Seenappa, Lochana M., Palmer, Erica, Zhang, Jeff, Haqq, Christopher M., DeMuth, Peter C., Khanna, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409721/ https://www.ncbi.nlm.nih.gov/pubmed/37553346 http://dx.doi.org/10.1038/s41467-023-39770-1

Ejemplares similares

A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2
por: Steinbuck, Martin P., et al.
Publicado: (2021)

A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
por: Dasari, Vijayendra, et al.
Publicado: (2022)

Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates
por: Seenappa, Lochana M., et al.
Publicado: (2022)

'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
por: Sinha, Debottam, et al.
Publicado: (2021)

Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients
por: Dasari, Vijayendra, et al.
Publicado: (2016)

Rapid whole‐blood assay to detect SARS‐CoV‐2‐specific memory T‐cell immunity following a single dose of AstraZeneca ChAdOx1‐S COVID‐19 vaccine
por: Lineburg, Katie E, et al.
Publicado: (2021)

Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity
por: Dasari, Vijayendra, et al.
Publicado: (2014)

Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases
por: Lineburg, Katie E, et al.
Publicado: (2020)

Ablation of CD8(+) T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3
por: Swaminathan, Srividhya, et al.
Publicado: (2022)

HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters
por: Huang, Xin, et al.
Publicado: (2012)

HLA alleles modulate EBV viral load in multiple sclerosis
por: Agostini, Simone, et al.
Publicado: (2018)

Pre-clinical development of T-cell immunotherapy for covid-19
por: Smith, C., et al.
Publicado: (2021)

EBV protection‐ and susceptibility‐related HLA alleles and EBV status in the Chinese population: A single‐center study
por: Suolitiken, Dina, et al.
Publicado: (2022)

HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients
por: Fletcher, Luke B., et al.
Publicado: (2017)

The impact of HLA class I and EBV latency‐II antigen‐specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
por: Jones, K., et al.
Publicado: (2015)

B cell-derived circulating granzyme B is a feature of acute infectious mononucleosis
por: Hagn, Magdalena, et al.
Publicado: (2015)

HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China
por: Huang, Xin, et al.
Publicado: (2012)

Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation
por: Tedeschi, Valentina, et al.
Publicado: (2019)

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
por: Panikkar, Archana, et al.
Publicado: (2022)

HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
por: Vietzen, Hannes, et al.
Publicado: (2023)

Proteome‐wide analysis of T‐cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile
por: Ambalathingal, George R, et al.
Publicado: (2020)

Limited Recognition of Highly Conserved Regions of SARS-CoV-2
por: Swaminathan, Srividhya, et al.
Publicado: (2022)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
por: Trinh, Cua Thi Hong, et al.
Publicado: (2023)

PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV+ Hodgkin Lymphoma
por: Liu, Yuxuan, et al.
Publicado: (2013)

Modeling HLA associations with EBV‐positive and ‐negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis
por: Johnson, Paul C.D., et al.
Publicado: (2015)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1
por: Tellam, Judy T., et al.
Publicado: (2012)

Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2021)

Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes
por: Bieling, Maren, et al.
Publicado: (2017)

Lack of HLA predominance and HLA shared epitopes in biliary Atresia
por: Mack, Cara L, et al.
Publicado: (2013)

EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

The little book of bulletproof investing: do's and don'ts to protect your financial life
por: Stein, Benjamin, et al.
Publicado: (2010)

The little book of alternative investments: reaping rewards by daring to be different
por: Stein, Benjamin, et al.
Publicado: (2011)

Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors
por: Sooda, Anuradha, et al.
Publicado: (2022)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells
por: Steinbuck, Martin Peter, et al.
Publicado: (2018)

Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry
por: Fujiwara, Kenji, et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2490k4l95ekted1fe7o7mubp6i